ERIN BRABANDT: Open Payments
NPI 1720152937 · CONOVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 37 payments from 15 companies in 2025. Trend: 2023 $17 · 2024 $237 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $194 |
| Corcept Therapeutics | 3 | $140 |
| AstraZeneca Pharmaceuticals LP | 2 | $140 |
| Lilly USA, LLC | 8 | $135 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Insulet Corporation | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Korlym, AIRSUPRA, Wegovy, MOUNJARO, ZEPBOUND, VOQUEZNA, Omnipod, Dexcom G6 Transmitter.
Industry payments across NC — which companies pay providers there.
